Global Inhaled Corticosteroid Market Research Report 2021

1 Inhaled Corticosteroid Market Overview

• 1.1 Product Overview and Scope of Inhaled Corticosteroid
• 1.2 Inhaled Corticosteroid Segment by Type
  • 1.2.1 Global Inhaled Corticosteroid Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Beclomethasone Dipropionate
  • 1.2.3 Budesonide
  • 1.2.4 Fluticasone Inhaler Powder
  • 1.2.5 Mometasone
  • 1.2.6 Others
• 1.3 Inhaled Corticosteroid Segment by Application
  • 1.3.1 Inhaled Corticosteroid Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Respiratory Care Centers
  • 1.3.5 Others
• 1.4 Global Inhaled Corticosteroid Market Size Estimates and Forecasts
  • 1.4.1 Global Inhaled Corticosteroid Revenue 2016-2027
  • 1.4.2 Global Inhaled Corticosteroid Sales 2016-2027
  • 1.4.3 Inhaled Corticosteroid Market Size by Region: 2016 Versus 2021 Versus 2027

2 Inhaled Corticosteroid Market Competition by Manufacturers

• 2.1 Global Inhaled Corticosteroid Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Inhaled Corticosteroid Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Inhaled Corticosteroid Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Inhaled Corticosteroid Manufacturing Sites, Area Served, Product Type
• 2.5 Inhaled Corticosteroid Market Competitive Situation and Trends
  • 2.5.1 Inhaled Corticosteroid Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Inhaled Corticosteroid Players Market Share by Revenue
  • 2.5.3 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhaled Corticosteroid Retrospective Market Scenario by Region

• 3.1 Global Inhaled Corticosteroid Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Inhaled Corticosteroid Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Inhaled Corticosteroid Market Facts & Figures by Country
  • 3.3.1 North America Inhaled Corticosteroid Sales by Country
  • 3.3.2 North America Inhaled Corticosteroid Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Inhaled Corticosteroid Market Facts & Figures by Country
  • 3.4.1 Europe Inhaled Corticosteroid Sales by Country
  • 3.4.2 Europe Inhaled Corticosteroid Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Inhaled Corticosteroid Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Inhaled Corticosteroid Sales by Region
  • 3.5.2 Asia Pacific Inhaled Corticosteroid Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Inhaled Corticosteroid Market Facts & Figures by Country
  • 3.6.1 Latin America Inhaled Corticosteroid Sales by Country
  • 3.6.2 Latin America Inhaled Corticosteroid Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Inhaled Corticosteroid Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Inhaled Corticosteroid Sales by Country
  • 3.7.2 Middle East and Africa Inhaled Corticosteroid Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Inhaled Corticosteroid Historic Market Analysis by Type

• 4.1 Global Inhaled Corticosteroid Sales Market Share by Type (2016-2021)
• 4.2 Global Inhaled Corticosteroid Revenue Market Share by Type (2016-2021)
• 4.3 Global Inhaled Corticosteroid Price by Type (2016-2021)

5 Global Inhaled Corticosteroid Historic Market Analysis by Application

• 5.1 Global Inhaled Corticosteroid Sales Market Share by Application (2016-2021)
• 5.2 Global Inhaled Corticosteroid Revenue Market Share by Application (2016-2021)
• 5.3 Global Inhaled Corticosteroid Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Sumitomo
  • 6.1.1 Sumitomo Corporation Information
  • 6.1.2 Sumitomo Description and Business Overview
  • 6.1.3 Sumitomo Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Sumitomo Product Portfolio
  • 6.1.5 Sumitomo Recent Developments/Updates
• 6.2 Pfizer
  • 6.2.1 Pfizer Corporation Information
  • 6.2.2 Pfizer Description and Business Overview
  • 6.2.3 Pfizer Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Pfizer Product Portfolio
  • 6.2.5 Pfizer Recent Developments/Updates
• 6.3 Novartis
  • 6.3.1 Novartis Corporation Information
  • 6.3.2 Novartis Description and Business Overview
  • 6.3.3 Novartis Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Novartis Product Portfolio
  • 6.3.5 Novartis Recent Developments/Updates
• 6.4 Merck
  • 6.4.1 Merck Corporation Information
  • 6.4.2 Merck Description and Business Overview
  • 6.4.3 Merck Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck Product Portfolio
  • 6.4.5 Merck Recent Developments/Updates
• 6.5 Sanofi
  • 6.5.1 Sanofi Corporation Information
  • 6.5.2 Sanofi Description and Business Overview
  • 6.5.3 Sanofi Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Sanofi Product Portfolio
  • 6.5.5 Sanofi Recent Developments/Updates
• 6.6 Johnson and Johnson
  • 6.6.1 Johnson and Johnson Corporation Information
  • 6.6.2 Johnson and Johnson Description and Business Overview
  • 6.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Johnson and Johnson Product Portfolio
  • 6.6.5 Johnson and Johnson Recent Developments/Updates
• 6.7 GSK
  • 6.6.1 GSK Corporation Information
  • 6.6.2 GSK Description and Business Overview
  • 6.6.3 GSK Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 GSK Product Portfolio
  • 6.7.5 GSK Recent Developments/Updates
• 6.8 AstraZeneca
  • 6.8.1 AstraZeneca Corporation Information
  • 6.8.2 AstraZeneca Description and Business Overview
  • 6.8.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 AstraZeneca Product Portfolio
  • 6.8.5 AstraZeneca Recent Developments/Updates
• 6.9 Teijin
  • 6.9.1 Teijin Corporation Information
  • 6.9.2 Teijin Description and Business Overview
  • 6.9.3 Teijin Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Teijin Product Portfolio
  • 6.9.5 Teijin Recent Developments/Updates
• 6.10 Glaxo's Advair
  • 6.10.1 Glaxo's Advair Corporation Information
  • 6.10.2 Glaxo's Advair Description and Business Overview
  • 6.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Glaxo's Advair Product Portfolio
  • 6.10.5 Glaxo's Advair Recent Developments/Updates
• 6.11 Amgen
  • 6.11.1 Amgen Corporation Information
  • 6.11.2 Amgen Inhaled Corticosteroid Description and Business Overview
  • 6.11.3 Amgen Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Amgen Product Portfolio
  • 6.11.5 Amgen Recent Developments/Updates
• 6.12 Kos Pharmaceutical
  • 6.12.1 Kos Pharmaceutical Corporation Information
  • 6.12.2 Kos Pharmaceutical Inhaled Corticosteroid Description and Business Overview
  • 6.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Kos Pharmaceutical Product Portfolio
  • 6.12.5 Kos Pharmaceutical Recent Developments/Updates
• 6.13 Teva Pharmaceutical
  • 6.13.1 Teva Pharmaceutical Corporation Information
  • 6.13.2 Teva Pharmaceutical Inhaled Corticosteroid Description and Business Overview
  • 6.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Teva Pharmaceutical Product Portfolio
  • 6.13.5 Teva Pharmaceutical Recent Developments/Updates

7 Inhaled Corticosteroid Manufacturing Cost Analysis

• 7.1 Inhaled Corticosteroid Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Inhaled Corticosteroid
• 7.4 Inhaled Corticosteroid Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Inhaled Corticosteroid Distributors List
• 8.3 Inhaled Corticosteroid Customers

9 Inhaled Corticosteroid Market Dynamics

• 9.1 Inhaled Corticosteroid Industry Trends
• 9.2 Inhaled Corticosteroid Growth Drivers
• 9.3 Inhaled Corticosteroid Market Challenges
• 9.4 Inhaled Corticosteroid Market Restraints

10 Global Market Forecast

• 10.1 Inhaled Corticosteroid Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Inhaled Corticosteroid by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Inhaled Corticosteroid by Type (2022-2027)
• 10.2 Inhaled Corticosteroid Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Inhaled Corticosteroid by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Inhaled Corticosteroid by Application (2022-2027)
• 10.3 Inhaled Corticosteroid Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Inhaled Corticosteroid by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Inhaled Corticosteroid by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List